Arcturus Therapeutics Ltd. Proceeds from Convertible Debt
Arcturus Therapeutics Ltd. reported Proceeds from Convertible Debt of $0 for the 9-month period ending 2018-09-30, per its 6-K filed 2018-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2019-03-18
- Arcturus Therapeutics Ltd. proceeds from convertible debt for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- Arcturus Therapeutics Ltd. proceeds from convertible debt for the quarter ending 2017-12-31 was $0.00.
- Arcturus Therapeutics Ltd. proceeds from convertible debt for the quarter ending 2017-09-30 was $161.00K.
- Arcturus Therapeutics Ltd. proceeds from convertible debt for fiscal 2017 was $5.65M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed | Proceeds from Convertible Debt 71 month |
|---|---|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $0.00 6-K · filed 2018-11-07 | ||||
| 2018-06-30 | $0.00 6-K · filed 2018-09-28 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 6-K 9 month · filed 2019-03-18 | $161.00K derived: sum of 2 quarters · filed 2019-03-18 | $5.65M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $161.00K derived: 6-K 9 month − 6-K 6 month · filed 2018-11-07 | $5.65M 6-K · filed 2018-11-07 | ||||
| 2017-06-30 | $5.49M 6-K · filed 2018-09-28 | |||||
| 2015-12-31 | $1.89M 20-F · filed 2018-05-14 | $0.00 20-F · filed 2016-03-04 | ||||
| 2014-12-31 | $0.00 20-F · filed 2016-03-04 | |||||
| 2013-12-31 | $115.00K 20-F · filed 2016-03-04 | $935.00K 20-F · filed 2014-03-28 | ||||
| 2012-12-31 | $600.00K 20-F · filed 2015-02-27 | |||||
| 2011-12-31 | $0.00 20-F · filed 2014-03-28 |